Peripheral Neuropathy Trial, Recruiting NCT06353568 Sponsor: University of Nove de Julho Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT06353568
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with type 2 diabetes (based on American Diabetes Association 2021 guidelines)
  • People of any sex
  • People between 18 and 75 years of age
  • People classified as moderate to high risk for developing diabetic foot problems, according to a specific international diabetic foot risk scale (IWGDF-2019) (confirm with trial site)

Who may not be able to join:

  • People who are pregnant
  • People diagnosed with type 1 diabetes
  • People who have nerve damage caused by poorly controlled conditions such as an underactive thyroid, low vitamin B12 levels, or heavy alcohol use
  • People who have an active infection at the time of joining the trial
  • People who have an open wound, active ulcer, or infected skin lesion on their legs or feet
  • People who have a history of bone infection (osteomyelitis)
  • People diagnosed with Parkinson's disease
  • People who have a condition causing permanent muscle or joint tightening (contracture)
  • People with severely reduced blood flow to the lower limbs, classified at a serious level on standard medical scales (Fontaine III/IV or Rutherford 4–6) (confirm with trial site)
  • People who have a suspicious skin lesion on their legs or feet that may indicate a growth or abnormal skin condition
  • People diagnosed with cancer, or who have received cancer treatment within the past 3 months
  • People who have experienced unstable chest pain, a recent heart attack, or serious heart rhythm problems within the past 6 months
  • People with severe chronic obstructive pulmonary disease (a serious lung condition) that is not well controlled
  • People who are unable to understand the informed consent form
  • People who are unable to attend appointments on a regular basis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kristianne KS Fernandes, PhD, University of Nove de Julho

Phone: +55 011 33859287

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Nove de Julho
Registry
ClinicalTrials.gov
Start date
30 March 2024
Est. completion
30 June 2025

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Ulcer Incidence; Ulcer Incidence; Ulcer Incidence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov